MedPath

Effect of Balneotherapy in Treatment of Fibromyalgia

Not Applicable
Conditions
fibromyalgia.
Fibromyalgia
Registration Number
IRCT20180108038268N4
Lead Sponsor
Ahi Evran University Scientific Research Projects Coordination Unit
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
35
Inclusion Criteria

18-50 years old
female
primer fibromyalgia diagnosed according to ACR 2016 diagnostic criteria

Exclusion Criteria

smoking
pregnancy and lactation
postmenopausal period
endocrine / rheumatic disease
renal and cardiovascular disease
presence of active infection
history of malignancy
using antioxidant, antidepressant, lipid lowering drug
had been treated for fibromyalgia in the last 3 months (drugs, balneotherapy, exercise therapy, etc...)
previous surgery in the last one year

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Oxidant and antioxidant status. Timepoint: Before intervention, after 15 sessions of balneotherapy (after 3 weeks). Method of measurement: Using an automated measurement method (Rel assay diagnostics kits).;Pain intensity. Timepoint: Before intervention, after 15 sessions of balneotherapy (after 3 weeks). Method of measurement: Visual Analog Scale (VAS).;Quality of life. Timepoint: Before intervention, after 15 sessions of balneotherapy (after 3 weeks). Method of measurement: Short Form 36 (SF-36).;Functional status in people with fibromiyalgia. Timepoint: Before intervention, after 15 sessions of balneotherapy (after 3 weeks). Method of measurement: Fibromyalgia Impact Questionnaire (FIQ).;Severity of depression. Timepoint: Before intervention, after 15 sessions of balneotherapy (after 3 weeks). Method of measurement: Beck Depression Inventory (BDI).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath